Your browser doesn't support javascript.
loading
Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials.
Takahashi, Kanji; Cheung, Chui Ming Gemmy; Iida, Tomohiro; Lai, Timothy Y Y; Ohji, Masahito; Yanagi, Yasuo; Kawano, Mika; Ohsawa, Shino; Suzuki, Tomoyuki; Kotecha, Aachal; Lin, Hugh; Patel, Vaibhavi; Swaminathan, Balakumar; Lee, Won Ki.
Afiliação
  • Takahashi K; Department of Ophthalmology, Kansai Medical University, School of Medicine, 2-5-1 Shinmachi, Hirakata City, Osaka, 573-1191, Japan. takahask@takii.kmu.ac.jp.
  • Cheung CMG; Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
  • Iida T; Tokyo Women's Medical University, Tokyo, Japan.
  • Lai TYY; Department of Ophthalmology and Visual Science, The Chinese University of Hong Kong, Hong Kong, New Territories, China.
  • Ohji M; Department of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan.
  • Yanagi Y; Department of Ophthalmology and Microtechnology, Yokohama City University, Yokohama, Japan.
  • Kawano M; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Ohsawa S; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Suzuki T; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Kotecha A; Roche Products Ltd., Welwyn Garden City, UK.
  • Lin H; Genentech, Inc., South San Francisco, CA, USA.
  • Patel V; Roche Products Ltd., Welwyn Garden City, UK.
  • Swaminathan B; F. Hoffman-La Roche Ltd., Mississauga, Canada.
  • Lee WK; Nune Eye Hospital, Seoul, South Korea.
Graefes Arch Clin Exp Ophthalmol ; 261(11): 3125-3137, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37294433

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article